Specialty Pharma Journal Specialty, Precision & Technology

KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced …

MONROVIA, Calif., Feb. 20, 2019 /PRNewswire/ — Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies …

NEW YORK and BRUSSELS, Feb. 20, 2019 /PRNewswire/ — The Global Commission to End the …

KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today …

Bagsværd, Denmark, 19 February 2019 – Novo Nordisk today announced that the US Food and Drug …

NEW ORLEANS & NEW YORK–(BUSINESS WIRE)–Ochsner Health System, Louisiana’s largest non-profit academic healthcare system, and …

NORTH CHICAGO, Ill., Feb. 19, 2019 /PRNewswire/ — AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, has …

ROCKVILLE, Md., Feb. 19, 2019 (GLOBE NEWSWIRE) — Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company …

BOSTON–(BUSINESS WIRE)–Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, today announced an …

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today shared additional clinical results from …

KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today …

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: …

NEW HAVEN, Conn., Feb. 19, 2019 /PRNewswire/ — Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) (“Biohaven”) …

Pfizer Inc. (NYSE: PFE) and Eli Lilly and Company (NYSE: LLY) today announced positive top-line results from …

DUBLIN and BOULDER, Colo., Feb. 19, 2019 /PRNewswire/ — Alkermes plc (Nasdaq: ALKS) and Clovis …